The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer
Noncoding ribonucleic acids (ncRNAs) have surfaced as essential orchestrators within the
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …
Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer
Simple Summary Researchers have spent nearly two decades unraveling the roles of non-
coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …
coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …
[HTML][HTML] Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - ncbi.nlm.nih.gov
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
Non-coding RNAs in lung tumor initiation and progression
RM Santos, C Moreno, WC Zhang - International Journal of Molecular …, 2020 - mdpi.com
Lung cancer is one of the deadliest forms of cancer affecting society today. Non-coding
RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs …
RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs …
Exploring clinical implications and role of non-coding RNAs in lung carcinogenesis
S Roy, N Ganguly, S Banerjee - Molecular Biology Reports, 2022 - Springer
Lung cancer is the utmost familiar category of cancer with greatest fatality rate worldwide
and several regulatory mechanisms exercise cellular control on critical oncogenic trails …
and several regulatory mechanisms exercise cellular control on critical oncogenic trails …
Emerging role of noncoding RNAs in EGFR TKI-resistant lung cancer
J Li, P Li, J Shao, S Liang, Y Wan, Q Zhang, C Li, Y Li… - Cancers, 2022 - mdpi.com
Simple Summary The introduction of epidermal growth factor receptor (EGFR)-tyrosine
kinase inhibitors (TKIs) has revolutionized the treatment of lung cancer. Nevertheless, TKI …
kinase inhibitors (TKIs) has revolutionized the treatment of lung cancer. Nevertheless, TKI …
Non-Coding RNAs as Key Regulators in Lung Cancer
I Gilyazova, G Gimalova, A Nizamova… - International Journal of …, 2023 - mdpi.com
For several decades, most lung cancer investigations have focused on the search for
mutations in candidate genes; however, in the last decade, due to the fact that most of the …
mutations in candidate genes; however, in the last decade, due to the fact that most of the …
Beyond the Genome: lncRNAs as Regulators of the PI3K/AKT Pathway in Lung Cancer
WH Almalki - Pathology-Research and Practice, 2023 - Elsevier
Lung cancer is a prevalent and devastating disease, representing a significant global health
burden. Despite advancements in therapeutic strategies, the molecular mechanisms …
burden. Despite advancements in therapeutic strategies, the molecular mechanisms …
[HTML][HTML] The role of selected non-coding RNAs in the biology of non-small cell lung cancer
K Kiełbowski, K Ptaszyński, J Wojcik… - Advances in Medical …, 2023 - Elsevier
Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
Major tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancer
K Inamura - Cells, 2017 - mdpi.com
Lung cancer is the leading cause of cancer deaths worldwide, yet there remains a lack of
specific and sensitive tools for early diagnosis and targeted therapies. High-throughput …
specific and sensitive tools for early diagnosis and targeted therapies. High-throughput …